Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
![GlobeNewswire](../../../Content/images/providers/GN.png)
Yield10 Bioscience, Inc. (YTEN)
US:NASDAQ Investor Relations:
ir.yield10bio.com/investor-relations
Company Research
Source: GlobeNewswire
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”) has granted to the Company an exclusive global, commercial license to advanced technology for producing sustainable omega-3 products in Camelina sativa (“Camelina”). Yield10 is executing a plan to use engineered Camelina to commercially produce omega-3 oil and meal products targeting the aquafeed, petfood, and nutritional markets for omega-3 fatty acids. In consideration for the commercial license, Yield10 is expected to pay certain license fees, future milestone payments, and royalties based on commercialization of Rothamsted’s omega-3 technology. Producing omega-3 fatty acids in engineered Camelina may represent a way to enable a predictable, land-based supply of high-quality omega-3 oils to meet the growing global demand for
Show less
Read more
Impact Snapshot
Event Time:
YTEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
YTEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
YTEN alerts
High impacting Yield10 Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
YTEN
News
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide LabelGlobeNewswire
- Yield10 Bioscience Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Yield10 Bioscience Announces First Quarter 2024 Financial ResultsGlobeNewswire
YTEN
Earnings
- 11/14/23 - Miss
YTEN
Sec Filings
- 6/12/24 - Form 8-K
- 6/10/24 - Form 8-K
- 5/28/24 - Form S-1/A
- YTEN's page on the SEC website